Intended Use
To qualitatively detect Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) DNA simultaneously in human clinical specimens using real-time PCR.
Specimen Required
Urogenital swabs – cervical, urethral; Urine samples.
Patient Preparation
- Sample Collection: Collect specimens using sterile techniques to avoid contamination.
- Specimen Preparation:
- Swab: Place immediately into appropriate transport medium if required.
- Urine: Collect in a clean, nonmetal container without preservatives if the specimen is maintained refrigerated or on ice during collection and transport to the laboratory.
- Storage/Transport Temperature: Refrigerated
- Unacceptable Conditions: Specimens in swab transport media without a swab; Under- or over-filled tubes of Urine container.
- Remarks: Proper aseptic technique and sample handling are critical to avoid contamination or degradation.
- Stability:
- Swab: Ambient: 2 months; Refrigerated: 2 months; Frozen: 1 year
- Urine: Ambient: 90 days; Refrigerated: 90 days; Frozen: Unacceptable.
Methodology
The test uses real-time PCR, multiplex format to amplify, detect, and identify the specific DNA sequences of CT and NG.
Sample Received to Report Turnaround Time (TAT)
Twice in a week (Scheduled Test)
Reference Interval
Positive or negative for presence of CT and/or NG DNA.
Interpretive Data
Refer to the Report.
Resources
- Additional Technical Information
- Test Request Form
Sample Reports
- Enhanced Report
- See report
